Nexalin Technology

NXLNasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$7.768 M

$0.35 +4.22%

Close of 7 Aug 2026

Revenue

$301.6K

#3574 by revenue

Earnings

-$8.22M

Loss-making

Shares outstanding

20,581,646

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus — ranked by market cap

All 28 →

#22Qt ImagingQTI$37.6M
#23IridexIRIX$14.5M
#24Nexalin TechnologyNXL$7.77M
#25ENDRA Life SciencesNDRA$5.71M
#26iTonicITOC$4.91M

Where these numbers come from

Share counts and financials for Nexalin Technology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.